14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 13, 2026
ABBNY vs IRBT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 13, 2026, iRobot Corporation (IRBT) is the stronger overall head-to-head candidate over ABBNY (ABBNY) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABBNY carries a Unified Composite Score of 55.7/100 (HOLD) at $83.75 (N/M Forward P/E, N/A operating margin), whereas IRBT carries 47.0/100 (HOLD) at $0.46 (N/M Forward P/E, -12.1% operating margin).
Composite vs. Pillar Nuance: While ABBNY currently prints a higher short-term Unified Composite Score (55.7/100 HOLD vs. IRBT 47.0/100 HOLD), IRBT captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-12.1% vs. N/A operating margin) and revenue trajectory (-24.6% vs. N/A YoY).
Technical & Structure Timing Caution: ABBNY is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.1); meanwhile IRBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABBNY vs IRBT. Trailing 12-month operating profitability (ABBNY N/A vs IRBT -12.1%) and valuation multiples (ABBNY N/M vs IRBT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Furnishings, Fixtures & Appliances value chain with $21.2M market capitalization and -12.1% operating margin.
OpEx & R&D Reinvestment47.3% of Rev ($740M)
90D Engineering Disclosures0 Published
Investor FAQ ABBNY vs IRBT Key Questions & Quantitative Answers
As of Nov 13, 2026, iRobot Corporation (IRBT) is the stronger overall head-to-head candidate over ABBNY (ABBNY) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ABBNY carries a Unified Composite Score of 55.7/100 (HOLD) at $83.75 (N/M Forward P/E, N/A operating margin), whereas IRBT carries 47.0/100 (HOLD) at $0.46 (N/M Forward P/E, -12.1% operating margin). Composite vs. Pillar Nuance: While ABBNY currently prints a higher short-term Unified Composite Score (55.7/100 HOLD vs. IRBT 47.0/100 HOLD), IRBT captures the overall institutional head-to-head verdict (5–3 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-12.1% vs. N/A operating margin) and revenue trajectory (-24.6% vs. N/A YoY). Technical & Structure Timing Caution: ABBNY is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.1); meanwhile IRBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
IRBT leads the Growth & Scale pillar: ABBNY posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IRBT at -24.6% YoY revenue growth and -37.0% YoY earnings growth on $1.56B TTM revenue (35.2% gross margin, -12.1% operating margin). On trailing 12-month operating scale, ABBNY generates N/A in USD-normalized revenue versus $1.56B for IRBT. In operating R&D and SG&A reinvestment, ABBNY deploys N/A (0 90-day corporate R&D disclosures) versus 47.3% of Rev ($740M) (0 disclosures) for IRBT.
IRBT screens cheaper on headline valuation multiples. ABBNY trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IRBT trades at N/M Forward P/E, N/M Trailing P/E, 2.72x PEG, and N/M EV/Revenue (2.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ABBNY (N/A ROE) versus IRBT (4.0% ROE) capital efficiency.
In options market volatility and institutional positioning, ABBNY carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.81β · 41% Vol realized risk). By comparison, IRBT carries 165.7% implied volatility (31st %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.15β · 460% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 13, 2026. For educational research only; not investment advice.